Similar to the hematological malignancies, a loss of heterozygosity of c-Cbl was noted in lung cancer and its combinatorial effect with other mutations such as EGFR or Met was proposed as a mechanism of tumorigenesis [21, 22]. The gene discussed is CBL; the disease is lung carcinoma.